Lawmakers move to ban cancer-causing chemicals from farmlands — here's what's happening
Costa Rican lawmakers have moved to ban a number of highly hazardous pesticides in an effort to reduce the number of chemicals used on farmland.
According to The Tico Times, a bill being discussed by representatives on the Special Permanent Commission on Environment would ban pesticides that meet the World Health Organization's international criteria for high toxicity and those with evidence of causing cancer or genetic mutation or affecting reproduction, according to the Globally Harmonized System.
The bill would require the ministries of Environment and Energy, Health, and Agriculture and Livestock to update the national list of banned pesticides every two years based on new information from the WHO and increase training so farmers in Costa Rica know their options when it comes to pesticides.
The bill would represent a massive change to the way Costa Rica approaches farming. Estimates have shown that Costa Rica ranks among the biggest users of pesticides per agricultural area, ranging between 10 and 35 kilograms of pesticides used per hectare of farmland. Making matters worse, eight of the 10 most frequently used pesticides in the country are classified as highly hazardous by the Regional Institute for Studies on Toxic Substances at the National University of Costa Rica.
Pesticides have become an increasingly controversial subject in agriculture. Many see them as essential to reducing crop loss, but chemicals in pesticides can cause serious issues. Recent studies indicate that certain pesticides can wreak havoc on the endocrine system. Other studies have shown that chemicals in pesticides linger on fruits and vegetables after they've been harvested and washed — and washed again at home. In the United Kingdom, studies have shown that perfluoroalkyl and polyfluoroalkyl substances have been found all over fruits and vegetables.
The bill would represent a profound shift toward healthier, more environmentally friendly agricultural practices in Costa Rica, which would benefit not just the Central American country but also its trade partners, including the United States.
Do you think gas stoves should be banned nationwide?
No way
Let each state decide
I'm not sure
Definitely
Click your choice to see results and speak your mind.
Join our free newsletter for good news and useful tips, and don't miss this cool list of easy ways to help yourself while helping the planet.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 hours ago
- Yahoo
Why has there been a global surge of new Covid variant NB.1.8.1?
India is the latest country to report a surge in new Covid cases, as the latest variant NB.1.8.1 spreads across the globe. Cases have now been reported in Asian countries such as Thailand, Indonesia and China, while the UKHSA recorded the first 13 cases in England last week. However, the true numbers are unlikely to be known, given the significant decrease in the number of people testing compared to the figures seen during the global pandemic five years ago. NB.1.8.1 stemmed from the Omicron variant and was first detected in January this year. It has quickly spread across China and Hong Kong, and has now been recorded in several states across the United States and Australia. By late April, NB.1.8.1 comprised about 10.7 per cent of submitted sequences globally, according to the World Health Organization (WHO). This rose from just 2.5 per cent one month before. The WHO declared the NB.1.8.1 strain a 'variant under monitoring' on 23 May, which means scientists believe it could potentially affect the behaviour of the virus. Lara Herrero, a virologist from Griffith University in Australia, suspects that NB.1.8.1 spreads more easily than other variants. 'Using lab-based models, researchers found NB.1.8.1 had the strongest binding affinity to the human ACE2 receptor of several variants tested, suggesting it may infect cells more efficiently than earlier strains,' Dr Herrero wrote last month in The Conversation. Dr Chun Tang, GP at Pall Mall Medical, added: 'NB.1.8.1 isn't too different from the Omicron variant, but it does have some tweaks to its spike protein, which might make it spread a bit more easily or slip past some of our existing immunity. 'That said, early signs suggest it doesn't seem to cause more serious illness, but of course, we're still learning more about it.' 'Its spread has been identified in around 22 countries,' said Dr Naveed Asif, GP at The London General Practice. 'The WHO assesses the additional risk to the global public as currently low, and existing Covid-19 vaccines are considered effective in preventing severe disease.' However, Nimbus does appear to be more transmissible than previous variants, with notable increases reported in India, Hong Kong, Singapore, and Thailand, notes Dr Asif. Common symptoms of the NB.1.8.1 variant include a severe sore throat. fatigue, mild cough, fever, muscle aches and congestion. It has also been reported that some patients have experienced gastrointestinal symptoms such as nausea and diarrhoea. Healthcare experts have stressed, however, that there is no evidence that the new strain is more deadly or serious than previous variants, and that current Covid vaccines are expected to remain effective and protect anyone infected from severe illness.
Yahoo
a day ago
- Yahoo
Supporting free science is a 'political and ethical' duty, Macron says
STORY: :: French President Emmanuel Macron makes a firm stand against skepticism towards climate science :: Monaco :: June 8, 2025 'For several years now, we've been hearing that, 'basically, climate change, the threat to biodiversity, the problem of the oceans, all of that is a matter of opinion. In fact, we could do without it. Besides, we're not entirely sure'. And I'm even noticing that some people are cutting funding to continue research in this area. I'm going to tell you, 'no', we don't have the right to do that because it's not an opinion, it's scientifically established.' // "And so it is a political, ethical, and scientific duty that we continue to fund free, open, and cooperative science, to continue to understand, research, and base our decisions on this science." Monaco hosted the two-day Blue Economy and Finance Forum (BEFF), a prelude to the week-long U.N. Ocean Conference in nearby Nice, which starts on Monday (June 9). The BEFF sought to outline financial advantages in protecting the oceans. Macron spoke to an audience that included Brazil's Luiz Inacio Lula da Silva, Costa Rican President Rodrigo Chaves and Britain's Prince William. He underlined efforts to promote sustainable fishing, decarbonized maritime transport, and green tourism. This week's U.N. conference aims to get more countries to ratify a treaty on protecting ocean biodiversity which currently lacks sufficient signatories to come into force.
Yahoo
a day ago
- Yahoo
Man who let snakes bite him 200 times spurs new antivenom hope
Tim Friede was feeling particularly down on the day after the September 11 attacks, so he went to his basement and let two of the world's deadliest snakes bite him. Four days later, he woke up from a coma. "I know what it feels like to die from snakebite," Friede told AFP via video call from his home in the small US town of Two Rivers, Wisconsin. This experience might put most people off snakes entirely, but Friede simply vowed to be more careful next time. From 2000 to 2018, he allowed himself to be bitten by snakes more than 200 times. He also injected himself with their venom over 650 times. Friede endured this pain because he wanted to achieve total immunity to venom, a practice called mithridatism which should not be tried at home. After a couple of years, Friede started to believe he could be the basis for a better kind of antivenom. The former truck mechanic, who does not have a university degree, long struggled to be taken seriously by scientists. But last month, a study published in the prestigious Cell journal showed that antibodies from his blood protect against a range of snake venom. The researchers now hope Friede's hyper-immunity could even lead to the development of a universal antivenom. This would fill a major need, because currently most antivenoms only cover one or a few of the world's 600 venomous snakes. Up to 138,000 people are killed by snakebites a year, while 400,000 suffer amputations or other disabilities, according to the World Health Organization. These figures are believed to be vastly underestimated because snakebite victims typically live in poorer, remote areas. - 'Pain every time' - Friede's first bite was from a harmless garter snake when he was five years old. "I was afraid, I cried, I ran away," said Friede, now 57. Then he started bringing snakes home and hiding them in pickle jars. His mother sought counselling, but his interest in snakes persisted. Things escalated after Friede attended a class that taught him how to "milk" snakes for their venom. How antivenom is made has changed little over the last 125 years. Small doses of snake venom are injected into animals such as horses, which produce antibodies that can be extracted and used as antivenom. However this antivenom usually only works for bites from that particular species of snake -- and it includes other antibodies from horse that can cause serious side-effects including anaphylactic shock. "I thought, well, if they make antivenom in horses, why can't I just use myself as a primate?" Friede said. He started working through the venom from all the deadly species he could get his hands on, such as cobras, taipans, black mambas and rattlesnakes. "There is pain every time," he said. - 'Proud' - For years, the scientists he contacted to take advantage of his immunity refused to bite. Then in 2017, immunologist Jacob Glanville, who previously worked on universal vaccines, turned his attention towards antivenom. Glanville told AFP he had been looking for "a clumsy snake researcher who'd been bit accidentally a couple times," when he came across a video of Friede taking brutal back-to-back snake bites. When they first spoke, Glanville said he told Friede: "I know this is awkward, but I would love to get my hands on some of your blood." "I've been waiting for this call for a long time," came the response, Glanville said. The antivenom described in the Cell paper includes two antibodies from Friede's blood, as well as a drug called varespladib. It offered mice full protection against 13 of the 19 snake species tested, and partial protection for the remaining six. The researchers hope a future cocktail will cover far more snakes -- particularly vipers -- with further trials planned on dogs in Australia. Timothy Jackson of the Australian Venom Research Unit praised the immunological research, but questioned whether a human needed to be involved, pointing to synthetically developed antibodies. Glanville said the ultimate goal of his US-based firm Centivax was to develop a universal antivenom administered by something like an EpiPen, potentially produced in India to keep the costs down. Friede said he was "proud" to have made a "small difference" in medical history. Now working for Centivax, Friede stopped self-inflicting himself with venom in 2018 to save the firm from liability issues. But he hopes to get bitten by snakes again in the future. "I do miss it," he said. dl/giv
